Literature DB >> 23840059

Cognitive and motivational deficits together with prefrontal oxidative stress in a mouse model for neuropsychiatric illness.

Alexander W Johnson1, Hanna Jaaro-Peled, Neelam Shahani, Thomas W Sedlak, Sandra Zoubovsky, Daniel Burruss, Francesco Emiliani, Akira Sawa, Michela Gallagher.   

Abstract

Guided by features of molecular, cellular, and circuit dysfunction affecting the prefrontal cortex in clinical investigations, we targeted prefrontal cortex in studies of a model for neuropsychiatric illness using transgenic mice expressing a putative dominant-negative disrupted in schizophrenia 1 (DN-DISC1). We detected marked augmentation of GAPDH-seven in absentia homolog Siah protein binding in the DISC1 mice, a major hallmark of a nuclear GAPDH cascade that is activated in response to oxidative stress. Furthermore, deficits were observed in well-defined tests for the cognitive control of adaptive behavior using reversal learning and reinforcer devaluation paradigms. These deficits occurred even though DN-DISC1 mice showed intact performance in simple associative learning and normal responses in consumption of reward. In an additional series of assessments, motivational functions also were impoverished in DN-DISC1 mice, including tests of the dynamic modulation of reward value by effortful action, progressive ratio performance, and social behavior. Augmentation of an oxidative stress-associated cascade (e.g., a nuclear GAPDH cascade) points to an underlying condition that may contribute to the profile of cognitive and motivational impairments in DN-DISC1 mice by affecting the functional integrity of the prefrontal cortex and dysfunction within its connected networks. As such, this model should be useful for further preclinical research and drug discovery efforts relevant to the burden of prefrontal dysfunction in neuropsychiatric illness.

Entities:  

Keywords:  cognition; depression; orbitofrontal cortex

Mesh:

Year:  2013        PMID: 23840059      PMCID: PMC3725079          DOI: 10.1073/pnas.1307925110

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  50 in total

1.  Bilateral orbital prefrontal cortex lesions in rhesus monkeys disrupt choices guided by both reward value and reward contingency.

Authors:  Alicia Izquierdo; Robin K Suda; Elisabeth A Murray
Journal:  J Neurosci       Date:  2004-08-25       Impact factor: 6.167

2.  Schizophrenia and affective disorders--cosegregation with a translocation at chromosome 1q42 that directly disrupts brain-expressed genes: clinical and P300 findings in a family.

Authors:  D H Blackwood; A Fordyce; M T Walker; D M St Clair; D J Porteous; W J Muir
Journal:  Am J Hum Genet       Date:  2001-07-06       Impact factor: 11.025

3.  Dissociating valence of outcome from behavioral control in human orbital and ventral prefrontal cortices.

Authors:  John O'Doherty; Hugo Critchley; Ralf Deichmann; Raymond J Dolan
Journal:  J Neurosci       Date:  2003-08-27       Impact factor: 6.167

Review 4.  DISC1 at 10: connecting psychiatric genetics and neuroscience.

Authors:  David J Porteous; J Kirsty Millar; Nicholas J Brandon; Akira Sawa
Journal:  Trends Mol Med       Date:  2011-10-19       Impact factor: 11.951

5.  Selective deficits in prefrontal cortical GABAergic neurons in schizophrenia defined by the presence of calcium-binding proteins.

Authors:  Clare L Beasley; Zhi J Zhang; Iain Patten; Gavin P Reynolds
Journal:  Biol Psychiatry       Date:  2002-10-01       Impact factor: 13.382

6.  Neuropsychological functioning of first-episode schizophreniform patients.

Authors:  A L Hoff; H Riordan; D W O'Donnell; L Morris; L E DeLisi
Journal:  Am J Psychiatry       Date:  1992-07       Impact factor: 18.112

Review 7.  Amygdala-frontal interactions and reward expectancy.

Authors:  Peter C Holland; Michela Gallagher
Journal:  Curr Opin Neurobiol       Date:  2004-04       Impact factor: 6.627

8.  Subcortical dopaminergic deficits in a DISC1 mutant model: a study in direct reference to human molecular brain imaging.

Authors:  Hanna Jaaro-Peled; Minae Niwa; Catherine A Foss; Rina Murai; Samantha de Los Reyes; Atsushi Kamiya; Yolanda Mateo; Patricio O'Donnell; Nicola G Cascella; Toshitaka Nabeshima; Tomás R Guilarte; Martin G Pomper; Akira Sawa
Journal:  Hum Mol Genet       Date:  2013-01-11       Impact factor: 6.150

9.  Sociability and preference for social novelty in five inbred strains: an approach to assess autistic-like behavior in mice.

Authors:  S S Moy; J J Nadler; A Perez; R P Barbaro; J M Johns; T R Magnuson; J Piven; J N Crawley
Journal:  Genes Brain Behav       Date:  2004-10       Impact factor: 3.449

10.  Regional studies of catecholamines in the rat brain. I. The disposition of [3H]norepinephrine, [3H]dopamine and [3H]dopa in various regions of the brain.

Authors:  J Glowinski; L L Iversen
Journal:  J Neurochem       Date:  1966-08       Impact factor: 5.372

View more
  53 in total

1.  Glutathione deficit impairs myelin maturation: relevance for white matter integrity in schizophrenia patients.

Authors:  A Monin; P S Baumann; A Griffa; L Xin; R Mekle; M Fournier; C Butticaz; M Klaey; J H Cabungcal; P Steullet; C Ferrari; M Cuenod; R Gruetter; J P Thiran; P Hagmann; P Conus; K Q Do
Journal:  Mol Psychiatry       Date:  2014-08-26       Impact factor: 15.992

2.  BDNF overexpression prevents cognitive deficit elicited by adolescent cannabis exposure and host susceptibility interaction.

Authors:  Hadar Segal-Gavish; Neta Gazit; Yael Barhum; Tali Ben-Zur; Michal Taler; Shay Henry Hornfeld; Irit Gil-Ad; Abraham Weizman; Inna Slutsky; Minae Niwa; Atsushi Kamiya; Akira Sawa; Daniel Offen; Ran Barzilay
Journal:  Hum Mol Genet       Date:  2017-07-01       Impact factor: 6.150

3.  Abnormal wake/sleep pattern in a novel gain-of-function model of DISC1.

Authors:  Hanna Jaaro-Peled; Cara Altimus; Tara LeGates; Tyler Cash-Padgett; Sandra Zoubovsky; Takatoshi Hikida; Koko Ishizuka; Samer Hattar; Valérie Mongrain; Akira Sawa
Journal:  Neurosci Res       Date:  2016-06-26       Impact factor: 3.304

Review 4.  Translating advances in the molecular basis of schizophrenia into novel cognitive treatment strategies.

Authors:  Colm M P O'Tuathaigh; Paula M Moran; Xuechu C Zhen; John L Waddington
Journal:  Br J Pharmacol       Date:  2017-08-03       Impact factor: 8.739

5.  Assessing Reality Testing in Mice Through Dopamine-Dependent Associatively Evoked Processing of Absent Gustatory Stimuli.

Authors:  Benjamin R Fry; Nicollette Russell; Ryan Gifford; Cindee F Robles; Claire E Manning; Akira Sawa; Minae Niwa; Alexander W Johnson
Journal:  Schizophr Bull       Date:  2020-01-04       Impact factor: 9.306

6.  Oxidative/Nitrosative stress in psychiatric disorders: are we there yet?

Authors:  Patricio O'Donnell; Kim Q Do; Celso Arango
Journal:  Schizophr Bull       Date:  2014-04-08       Impact factor: 9.306

Review 7.  Oxidative stress and schizophrenia: recent breakthroughs from an old story.

Authors:  Francesco E Emiliani; Thomas W Sedlak; Akira Sawa
Journal:  Curr Opin Psychiatry       Date:  2014-05       Impact factor: 4.741

Review 8.  Bridging Autism Spectrum Disorders and Schizophrenia through inflammation and biomarkers - pre-clinical and clinical investigations.

Authors:  Joana Prata; Susana G Santos; Maria Inês Almeida; Rui Coelho; Mário A Barbosa
Journal:  J Neuroinflammation       Date:  2017-09-04       Impact factor: 8.322

Review 9.  Psychiatric behaviors associated with cytoskeletal defects in radial neuronal migration.

Authors:  Toshifumi Fukuda; Shigeru Yanagi
Journal:  Cell Mol Life Sci       Date:  2017-05-17       Impact factor: 9.261

10.  Translocator protein (TSPO) and stress cascades in mouse models of psychosis with inflammatory disturbances.

Authors:  Daisuke Fukudome; Lindsay N Hayes; Travis E Faust; Catherine A Foss; Mari A Kondo; Brian J Lee; Atsushi Saito; Shin-Ichi Kano; Jennifer M Coughlin; Atsushi Kamiya; Martin G Pomper; Akira Sawa; Minae Niwa
Journal:  Schizophr Res       Date:  2018-02-03       Impact factor: 4.939

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.